Interferon-γ Induces Senescence in Normal Human Melanocytes

Vitiligo: interplay between oxidative stress and immune system

(2013) Naresh C. Laddha et al.   EXPERIMENTAL DERMATOLOGY

Vitiligo: A Possible Model of Degenerative Diseases

(2013) Barbara Bellei et al.   PLoS One

Mutant HSP70 Reverses Autoimmune Depigmentation in Vitiligo

(2013) J. A. Mosenson et al.   Science Translational Medicine

Over-expression of tumor necrosis factor-α in vitiligo lesions after narrow-band UVB therapy: an immunohistochemical study

(2012) Enayat Attwa et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Epidermis instructs skin homing receptor expression in human T cells

(2012) M. L. McCully et al.   BLOOD

In vitro research on vitiligo: strategies, principles, methodological options and common pitfalls

(2012) Maria Lucia Dell'Anna et al.   EXPERIMENTAL DERMATOLOGY

IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells

(2012) Shuguang Zuo et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin

(2012) John E. Harris et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Vitiligo-Inducing Phenols Activate the Unfolded Protein Response in Melanocytes Resulting in Upregulation of IL6 and IL8

(2012) Siavash Toosi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

(2012) K. Ezzedine et al.   Pigment Cell & Melanoma Research

Global Activation of CD8+ Cytotoxic T Lymphocytes Correlates with an Impairment in Regulatory T Cells in Patients with Generalized Vitiligo

(2012) Yang Lili et al.   PLoS One

Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets

(2011) H. Seif El Nasr et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

HSP70i is a critical component of the immune response leading to vitiligo

(2011) Jeffrey A. Mosenson et al.   Pigment Cell & Melanoma Research

Pathways of oncogene-induced senescence in human melanocytic cells

(2010) Rajat Bansal et al.   CELL CYCLE

The essence of senescence

(2010) T. Kuilman et al.   GENES & DEVELOPMENT

Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice

(2010) Randal K. Gregg et al.   JOURNAL OF IMMUNOLOGY

DDB2, an Essential Mediator of Premature Senescence

(2010) Nilotpal Roy et al.   MOLECULAR AND CELLULAR BIOLOGY

Reduced skin homing by functional Treg in vitiligo

(2010) Jared Klarquist et al.   Pigment Cell & Melanoma Research

Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo

(2009) Z. Zhou et al.   BRITISH JOURNAL OF DERMATOLOGY

Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?

(2009) Lübeck Ralf Paus et al.   EXPERIMENTAL DERMATOLOGY

Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients

(2009) Jasper G. van den Boorn et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A heat shock protein gene (Hsp70.1) is critically involved in the generation of the immune response to myelin antigen

(2008) Marcin P. Mycko et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

HSP70i Accelerates Depigmentation in a Mouse Model of Autoimmune Vitiligo

(2008) Cecele J. Denman et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The role of helper and regulatory T cells in the pathogenesis of vitiligo

(2008) Pinar Y. Basak et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY